Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Normal B-lymphocyte maturation and proliferation are regulated by chemotactic cytokines (chemokines), and genetic polymorphisms in chemokines and chemokine receptors modify progression of human immunodeficiency virus-1 (HIV-1) infection. Therefore, 746
HIV
-1-infected persons were examined for associations of previously described stromal cell-derived factor 1 (SDF-1) chemokine and CCR5 and
CCR2
chemokine receptor gene variants with the risk of B-cell non-Hodgkin's lymphoma (NHL). The SDF1-3'A chemokine variant, which is carried by 37% of whites and 11% of blacks, was associated with approximate doubling of the NHL risk in heterozygotes and roughly a fourfold increase in homozygotes. After a median follow-up of 11.7 years, NHL developed in 6 (19%) of 30 SDF1-3'A/3'A homozygotes and 22 (10%) of 202 SDF1-+/3'A heterozygotes, compared with 24 (5%) of 514 wild-type subjects. The acquired immunodeficiency syndrome (AIDS)-protective chemokine receptor variant CCR5-triangle up32 was highly protective against NHL, whereas the AIDS-protective variant
CCR2
-64I had no significant effect. Racial differences in SDF1-3'A frequency may contribute to the lower risk of
HIV
-1-associated NHL in blacks compared with whites. SDF-1 genotyping of
HIV
-1-infected patients may identify subgroups warranting enhanced monitoring and targeted interventions to reduce the risk of NHL.
...
PMID:Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. 1006 55
Three genes which have variants acting as anti-
HIV
-1 were described so far. Among three, two are genes encoding receptors for chemokines, namely CCR5 and
CCR2
, which act as entry coreceptors for
HIV
-1 virus. The other gene is SDF1 gene. SDF-1, a cytokine belonging to the chemokine family has an inhibitory activity against the
HIV
-1 infection, because SDF-1 Is the physiological ligand for CXCR4, the entry coreceptor for T tropic
HIV
-1 virus. Recently, an SDF1 gene polymorphism was figured out to be one of the human genetic factors which regulate the period between the
HIV
-1 infection and the AIDS onset. By this finding, it was strongly suggested that SDF-1 regulates the onset of AIDS in the actual human population.
...
PMID:[Anti-HIV-1 genes; genetic restriction of AIDS pathogenesis by gene variants]. 1022 98
The frequencies of three mutations conferring resistance to
HIV
/AIDS were determined in a population sample of native Kuwaitis. The
CCR2
-641, SDF1-3'A, and CCR5-m303 mutations were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) tests using restriction endonucleases Bsa BI, Msp I, and Hinc II, respectively. The frequency of the mutant alleles were: for
CCR2
-641, 0.1195 (95% CI 0.0801-0.1694); for SDF1-3'A, 0.2593 (95% CI 0.2024-0.3231), and for CCR5-m303, less than 0.0025. Thus, the
CCR2
-641 and especially SDF1-3'A mutations are sufficiently common in Arabs and can be used for prognostic genotyping in
HIV
-infected individuals from the Gulf countries.
...
PMID:Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis. 1022 46
Human immunodeficiency virus type 1 (HIV-1) requires, in addition to CD4, coreceptors of the CC or CXC chemokine families for productive infection of T cells and cells of the monocyte-macrophage lineage. Based on the hypothesis that coreceptor expression on alveolar macrophages (AM) may influence
HIV
-1 infection of AM in the lung, this study analyzes the expression and utilization of
HIV
-1 coreceptors on AM of healthy individuals. AM were productively infected with five different primary isolates of
HIV
-1. Levels of surface expression of CCR5, CXCR4, and CD4 were low compared to those of blood monocytes, but CCR3 was not detectable. mRNA for CCR5, CXCR4,
CCR2
, and CCR3 were all detectable, but to varying degrees and with variability among donors. Expression of CCR5, CXCR4, and
CCR2
mRNA was downregulated following stimulation with lipopolysaccharide (LPS). In contrast, secretion of the chemokines RANTES, MIP-1alpha, and MIP-1beta was upregulated with LPS stimulation. Interestingly,
HIV
-1 replication was diminished following LPS stimulation. Infection of AM with
HIV
-1 in the presence of the CC chemokines demonstrated blocking of infection. Together, these studies demonstrate that AM can be infected by a variety of primary
HIV
-1 isolates, AM express a variety of chemokine receptors, the dominant coreceptor used for
HIV
entry into AM is CCR5, the expression of these receptors is dependent on the state of activation of AM, and the ability of
HIV
-1 to infect AM may be modulated by expression of the chemokine receptors and by chemokines per se.
...
PMID:Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. 1036 38
Heterozygosity for a 32-bp deletion in the CCR5 gene (CCR5 Delta32), which encodes the coreceptor for macrophage-tropic non-syncytium-inducing (NSI) human immunodeficiency virus type 1 (HIV-1) variants, results in a lower CCR5 expression and reduced NSI
HIV
-1 replication. Because infection of macrophages and microglial cells by NSI
HIV
-1 is considered to be instrumental for the development of AIDS dementia complex (ADC), we studied whether the CCR5 Delta32 heterozygous genotype correlated with a reduced frequency of ADC. Two (4.1%) of 49 patients with ADC versus 27 (14. 5%) of 186 AIDS patients without ADC were heterozygous for CCR5 Delta32 (P=.05). In contrast, a point mutation in the first transmembrane domain of
CCR2
(
CCR2
64I) did not show this protective effect (P=.57). The reduced prevalence of the CCR5 Delta32 allele among patients with ADC may indicate a reduced or absent reservoir of macrophage-tropic NSI
HIV
-1 in the brain of CCR5 Delta32 heterozygotes.
...
PMID:Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. 1043 79
Glucocorticoid hormones (GC) are potent antiinflammatory agents widely used in the treatment of diverse human diseases. The present study was aimed at assessing the effect of GC on chemokine receptor expression in human monocytes. Dexamethasone (Dex) up-regulated mRNA expression of the monocyte chemotactic protein (MCP-1, CCL2) chemokine receptor
CCR2
. The effect was selective in that other chemokine receptors were not substantially affected. Stimulation by Dex was observed after 4 h of exposure at concentrations of 10(-7) to 10(-5) M. Steroids devoid of GC activity were inactive, and the GC receptor antagonist, RU486, inhibited stimulation. Dex did not affect the rate of nuclear transcription, but augmented the
CCR2
mRNA half-life. Augmentation of
CCR2
expression by Dex was associated with increased chemotaxis. Finally, Dex treatment induced productive replication of the
HIV
strain 89.6, which utilizes
CCR2
as entry coreceptor, in freshly isolated monocytes. Together with previous findings, these results indicate that at least certain pro- and antiinflammatory molecules have reciprocal and divergent effects on expression of a major monocyte chemoattractant, MCP-1, and of its receptor (
CCR2
). Augmentation of monocyte
CCR2
expression may underlie unexplained in vivo effects of GC as well as some of their actions on
HIV infection
.
...
PMID:Up-regulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. 1047 27
Chemokine receptor
CCR2
and stromal-derived factor (SDF-1) are involved in
HIV infection
and AIDS symptom onset. Recent cohort studies showed that point mutations in these two genes,
CCR2
-64I and SDF1-3'A, can delay AIDS onset > or = 16 years after seroconversions. The protective effect of
CCR2
-64I is dominant, whereas that of SDF1-3'A is recessive. SDF1-3'A homozygotes also showed possible protection against
HIV
-1 infection. In this study, we surveyed the frequency distributions of the two alleles at both loci in world populations, with emphasis on those in east Asia. The
CCR2
-64I frequencies do not vary significantly in the different continents, having a range of 0.1-0.2 in most populations. A decreasing cline of the
CCR2
-64I frequency from north to south was observed in east Asia. In contrast, the distribution of SDF1-3'A in world populations varies substantially, and the highest frequency was observed in Oceanian populations. Moreover, an increasing cline of the SDF1-3'A frequency from north to south was observed in east Asia. The relative hazard values were computed to evaluate the risk of AIDS onset on the basis of two-locus genotypes in the east Asian and world populations.
...
PMID:Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I) in East Asian and world populations and its implication in AIDS epidemiology. 1048 23
The importance of chemokine expression on
HIV infection
has been emphasized by the discovery that infection of CD4(+) T cells by M-tropic strains of
HIV
-1 is antagonized by the chemokines RANTES, MIP-1alpha, and MIP-1beta, which are natural ligands of CCR5, a major coreceptor for macrophagetropic (M-tropic) isolates of
HIV
-1. Similarly, the CCR2b ligands MCP-1 and MCP-3 inhibit productive infection of PBMCs by both CCR5- and CXCR4-dependent strains of
HIV
-1, suggesting that expression of the MCP-1 chemokine may affect
HIV infection
via signaling through the
CCR2
receptor and subsequent desensitization of the CCR5 and/or CXCR4 signaling pathway. Given the major role played by chemokine receptors in
HIV
-1 fusion/entry and the regulatory effects of chemokines on
HIV
-1 infection, we examined the pattern of chemokine gene expression in
HIV
-1-infected myeloid cells and in primary monocyte/macrophages. Chronic
HIV
-1 infection of U937 monocytic cells increased the expression of RANTES, MIP-1alpha, MIP-1beta, and IL-8 chemokine genes, but strongly inhibited PMA/PHA- and TNFalpha-induced MCP-1 gene transcription.
HIV
-1-mediated inhibition of MCP-1 transcription and secretion was further confirmed in de novo
HIV
-1-infected U937 cells and correlated with a delay in
HIV
- and signal-induced NF-kappaB binding to the MCP-1 promoter. The inhibition of MCP-1 gene expression may provide a mechanism by which
HIV
-1 escapes the early influence of chemokine expression in monocytic cells.
...
PMID:Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. 1049 6
There are natural mutations in the coding and noncoding regions of the human immunodeficiency virus type 1 (HIV-1) CC-chemokine coreceptor 5 (CCR5) and in the related
CCR2
protein (the
CCR2
-64I mutation). Individuals homozygous for the CCR5-Delta32 allele, which prevents CCR5 expression, strongly resist
HIV
-1 infection. Several genetic polymorphisms have been identified within the CCR5 5' regulatory region, some of which influence the rate of disease progression in adult AIDS study cohorts. We genotyped 1,442 infants (1,235 uninfected and 207 HIV-1 infected) for five CCR5 and
CCR2
polymorphisms: CCR5-59353-T/C, CCR5-59356-C/T CCR5-59402-A/G, CCR5-Delta32, and
CCR2
-64I. The clinical significance of each genotype was assessed by measuring whether it influenced the rate of perinatal
HIV
-1 transmission among 667 AZT-untreated mother-infant pairs (554 uninfected and 113 HIV-1 infected). We found that the mutant CCR5-59356-T allele is relatively common in African-Americans (20.6% allele frequency among 552 infants) and rare in Caucasians and Hispanics (3.4 and 5.6% of 174 and 458 infants, respectively; P < 0.001). There were 38 infants homozygous for CCR5-59356-T, of whom 35 were African-Americans. Among the African-American infants in the AZT-untreated group, there was a highly significant increase in
HIV
-1 transmission to infants with two mutant CCR5-59356-T alleles (47.6% of 21), compared to those with no or one mutant allele (13.4 to 14.1% of 187 and 71, respectively; P < 0.001). The increased relative risk was 5.9 (95% confidence interval, 2.3 to 15.3; P < 0.001). The frequency of the CCR5-59356-T mutation varies between population groups in the United States, a low frequency occurring in Caucasians and a higher frequency occurring in African-Americans. Homozygosity for CCR5-59356-T is strongly associated with an increased rate of perinatal
HIV
-1 transmission.
...
PMID:A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. 1055 43
Genetic polymorphisms of CCR5 and
CCR2
human chemokine receptors have been associated with resistance during
HIV
-1 infection and disease progression. The protective effect of mutant alleles at these loci has important implications in AIDS pathogenesis. Chemokine receptors have a role in viral entry into target cells as well as in immune response modulation. In the present report, we studied the frequency of CCR5delta32 and CCR264I allelic variants among a representative sample of the Italian population. Observed allelic frequencies were 0.0454 and 0.0655, respectively. In both cases, genotype distribution was in equilibrium as predicted by the Hardy-Weinberg equation. Taken as a whole, about 21% of the population sample was found to be heterozygous for one or another of those two mutated alleles. Distribution of CCR5delta32 and CCR264I allelic variants within a population can be considered as a measure of genetic susceptibility to
HIV infection
and disease progression.
...
PMID:Allelic distribution of CCR5 and CCR2 genes in an Italian population sample. 1065 48
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>